Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02674763
Title Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Comprehensive Cancer Center (UAB CCC) Birmingham Alabama 35294 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
New Mexico Cancer Care Alliance Albuquerque New Mexico 87106 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Knight Cancer Institute - OSHU Portland Oregon 97239 United States Details
Baylor Scott & White University Medical Center Dallas Texas 75246 United States Details
The University of Texas, MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field